A Zika diagnostic test developed by Washington University School of Medicine in St. Louis was newly granted market authorisation by the Food and Drug Administration (FDA). According to a press release posted on the website of the university on Wednesday using an antibody as well as other components to detect anti-Zika antibodies in the blood of people recently infected with the virus the test can detect signs of Zika infection in serum samples within 12 weeks of infection the Xinhua news agency reported. The test is not meant to be used as a stand-alone proof of infection. The FDA recommends
